ALBEMARLE CORP (ALB-PA)
Income Statement
Consolidated Statement of Income
ALBEMARLE CORPORATION (ALB PR A)
Year Ended (In thousands, except shares and per share data)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | |
|---|---|---|---|
| Revenues | $5,142,733 | $5,377,526 | $9,617,203 |
| Unconsolidated Affiliates | $16,344 | $30,090 | $35,676 |
| Cost of goods sold | $4,474,014 | $5,314,987 | $8,431,294 |
| Related Party | $534,000 | $1,700,000 | $2,300,000 |
| Gross profit | $668,719 | $62,539 | $1,185,909 |
| Selling, general and administrative expenses | $550,036 | $618,048 | $910,002 |
| Goodwill impairment | $181,070 | ||
| Long-lived asset impairment charges | $245,600 | ||
| Restructuring charges and asset write-offs | $7,699 | $1,134,316 | $9,491 |
| Selling, general and administrative expenses | $2,200 | ||
| Other income, net | $26,100 | ||
| Research and development expenses | $51,398 | $86,720 | $85,725 |
| Gain on change in interest in properties/sale of business, net | $(71,190) | ||
| Operating (loss) profit | $(367,084) | $(1,776,545) | $251,881 |
| Interest and financing expenses | $(207,651) | $(165,619) | $(116,072) |
| Other income, net | $22,662 | $178,339 | $110,929 |
| (Loss) income before income taxes and equity in net income of unconsolidated investments | $(552,073) | $(1,763,825) | $246,738 |
| Income tax expense | $156,881 | $87,085 | $430,277 |
| Loss before equity in net income of unconsolidated investments | $(708,954) | $(1,850,910) | $(183,539) |
| Equity in net income of unconsolidated investments (net of tax) | $243,744 | $715,433 | $1,854,082 |
| Net (loss) income | $(465,210) | $(1,135,477) | $1,670,543 |
| Net income attributable to noncontrolling interests | $(45,418) | $(43,972) | $(97,067) |
| Net (loss) income attributable to Albemarle Corporation | (510,628) | (1,179,449) | 1,573,476 |
| Mandatory convertible preferred stock dividends | $(166,750) | $(136,647) | |
| Net (loss) income attributable to Albemarle Corporation common shareholders, basic | (677,378) | (1,316,096) | 1,573,476 |
| Net (loss) income attributable to Albemarle Corporation common shareholders, diluted | (677,378) | (1,316,096) | 1,573,476 |
| Basic earnings (loss) per share attributable to common shareholders (in dollars per share) | -5.76 | -11.20 | 13.41 |
| Diluted earnings (loss) per share attributable to common shareholders (in dollars per share) | -5.76 | -11.20 | 13.36 |
| Weighted-average common shares outstanding—basic (in shares) | 117,664 | 117,516 | 117,317 |
| Weighted-average common shares outstanding—diluted (in shares) | 117,664 | 117,516 | 117,766 |
Balance Sheet
Consolidated Balance Sheets
ALBEMARLE CORPORATION (ALB PR A)
As of December 31, 2025 and December 31, 2024 (In thousands, except shares and per share data)
| Dec 31, 2025 | Dec 31, 2024 | |
|---|---|---|
| Cash and cash equivalents | $1,618,001 | $1,192,230 |
| Trade accounts receivable, less allowance for credit losses (2025—$4,578; 2024—$5,201) | $593,502 | $742,201 |
| Other accounts receivable | $105,110 | $238,384 |
| Inventories | $1,179,271 | $1,502,531 |
| Other current assets | $140,440 | $166,916 |
| Current assets held for sale | $371,815 | |
| Total current assets | $4,008,139 | $3,842,262 |
| Property, plant and equipment, at cost | $11,768,840 | $12,523,368 |
| Less accumulated depreciation and amortization | $3,156,429 | $3,191,898 |
| Net property, plant and equipment | $8,612,411 | $9,331,470 |
| Investments | $900,926 | $1,117,739 |
| Other assets | $647,185 | $504,711 |
| Goodwill | $1,499,657 | $1,582,714 |
| Other intangibles, net of amortization | $214,233 | $230,753 |
| Noncurrent assets held for sale | $491,660 | |
| Total assets | $16,374,211 | $16,609,649 |
| Accounts payable | $913,529 | $943,887 |
| Nonrelated Party | $779,160 | $793,455 |
| Related Party | $134,369 | $150,432 |
| Accrued expenses | $521,831 | $467,997 |
| Current portion of long-term debt | $74,077 | $398,023 |
| Dividends payable | $61,387 | $61,282 |
| Income taxes payable | $35,467 | $95,275 |
| Current liabilities held for sale | $191,753 | |
| Total current liabilities | $1,798,044 | $1,966,464 |
| Long-term debt | $3,119,464 | $3,118,142 |
| Postretirement benefits | $44,744 | $31,930 |
| Pension benefits | $117,361 | $116,192 |
| Other noncurrent liabilities | $1,084,892 | $819,204 |
| Deferred income taxes | $368,275 | $358,029 |
| Noncurrent liabilities held for sale | $59,970 | |
| Commitments and contingencies | ||
| Common stock, $.01 par value (authorized 275,000 shares), issued and outstanding — 117,716 in 2025 and 117,560 in 2024 | $1,178 | $1,176 |
| Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized - 15,000, issued and outstanding - 2,300 in 2025 and 2024 | $2,235,105 | $2,235,105 |
| Additional paid-in capital | $3,018,213 | $2,985,606 |
| Accumulated other comprehensive loss | $(334,807) | $(742,062) |
| Retained earnings | $4,613,676 | $5,481,692 |
| Total Albemarle Corporation shareholders’ equity | 9,533,365 | 9,961,517 |
| Noncontrolling interests | $248,096 | $238,171 |
| Total equity | $9,781,461 | $10,199,688 |
| Total liabilities and equity | $16,374,211 | $16,609,649 |
Cash Flow
Consolidated Statement of Cash Flows
ALBEMARLE CORPORATION (ALB PR A)
Year Ended (In thousands, except shares and per share data)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | |
|---|---|---|---|
| Cash and cash equivalents at end of year | |||
| Net (loss) income | $(465,210) | $(1,135,477) | $1,670,543 |
| Depreciation and amortization | $658,678 | $588,638 | $429,944 |
| Non-cash goodwill impairment charges | $181,070 | ||
| Non-cash long-lived asset impairment charges | $245,600 | ||
| Non-cash restructuring and asset write-offs | $1,013,444 | ||
| Gain on change in interest in properties/sale of business, net | $(71,190) | ||
| Stock-based compensation and other | $40,271 | $32,141 | $36,545 |
| Equity in net income of unconsolidated investments (net of tax) | $(243,744) | $(715,433) | $(1,854,082) |
| Dividends received from unconsolidated investments and nonmarketable securities | $93,739 | $358,933 | $2,000,862 |
| Pension and postretirement expense (benefit) | $23,377 | $(5,274) | $(1,658) |
| Pension and postretirement contributions | $(20,441) | $(19,379) | $(17,866) |
| Realized loss on investments in marketable securities | $33,746 | ||
| Unrealized (gain) loss on investments in marketable securities | $(14,088) | $30,073 | $39,864 |
| Loss on early extinguishment of debt | $7,471 | ||
| Deferred income taxes | $81,169 | $(230,406) | $100,877 |
| Decrease (increase) in accounts receivable | $47,315 | $555,218 | $(350,655) |
| Decrease (increase) in inventories | $212,351 | $1,055,036 | $(353,564) |
| Decrease (increase) in other current assets | $4,027 | $244,987 | $(171,870) |
| Increase (decrease) in accounts payable to third parties | $128,145 | $(862,237) | $(283,411) |
| Nonrelated Party | $144,208 | $(462,839) | $(315,220) |
| Related Party | $(16,063) | $(399,398) | $31,809 |
| (Decrease) increase in accrued expenses and income taxes payable | $(36,753) | $(140,099) | $253,518 |
| Noncurrent liability changes and other, net | $339,290 | $(116,035) | $(101,274) |
| Net cash provided by operating activities | $1,282,267 | $687,876 | $1,326,583 |
| Acquisitions, net of cash acquired | $(426,228) | ||
| Capital expenditures | $(589,801) | $(1,680,529) | $(2,154,542) |
| Proceeds from sale of property and equipment | $32,812 | $29,102 | |
| Proceeds from sale from investments | $290,908 | ||
| Proceeds (payments) from settlement of foreign currency forward contracts, net | $114,236 | $(15,595) | $221,849 |
| Sales (purchases) of marketable securities, net | $6,077 | $82,520 | $(204,451) |
| Investments in equity investments and nonmarketable securities | $(239) | $(270) | $(1,200) |
| Net cash used in investing activities | $(146,007) | $(1,584,772) | $(2,564,572) |
| Proceeds from issuance of mandatory convertible preferred stock, net of issuance costs | $2,236,750 | ||
| Proceeds from borrowings of long-term debt and credit agreements | $56,728 | $112,439 | $356,047 |
| Repayments of long-term debt and credit agreements | $(505,736) | $(112,439) | $(28,862) |
| Other (repayments) borrowings, net | $(5,657) | $(631,834) | $617,014 |
| Dividends paid to common shareholders | $(190,530) | $(188,530) | $(187,188) |
| Dividends paid to mandatory convertible preferred shareholders | $(166,750) | $(122,746) | |
| Dividends paid to noncontrolling interests | $(18,169) | $(37,194) | $(105,631) |
| Proceeds from exercise of stock options | $3,240 | $374 | $190 |
| Withholding taxes paid on stock-based compensation award distributions | $(7,258) | $(11,891) | $(27,468) |
| Other | $(55) | $(3,194) | $(191) |
| Net cash (used in) provided by financing activities | $(834,187) | $1,241,735 | $623,911 |
| Net effect of foreign exchange on cash and cash equivalents | $123,698 | $(42,509) | $4,836 |
| Increase (decrease) in cash and cash equivalents | $425,771 | $302,330 | $(609,242) |
| Cash and cash equivalents at end of year |